How Do Testosterone Formulations Differ in Cardiovascular Risk?
Testosterone formulations differ in cardiovascular risk primarily through pharmacokinetic variations influencing hematocrit, estrogen balance, and metabolic markers.
HRTioJuly 22, 2025